Indogulf Cropsciences IPO Details
MAINBOARD
Indogulf Cropsciences IPO opens for subscription on 26 Jun 2025 and closes on 30 Jun 2025. The IPO will be listed on NSE, BSE with the tentative listing date set for 03 Jul 2025.
Indogulf Cropsciences IPO price band has been fixed at ₹105 – ₹111 per share.The face value is ₹10 per share with a lot size of 135.
Indogulf Cropsciences IPO total issue size comprises 1,80,18,017 shares (aggregating up to ₹200.00 Cr). This includes a fresh issue of 1,44,14,414 shares (aggregating up to ₹160.00 Cr). Offer for Sale consists of 36,03,603 shares (aggregating up to ₹40.00 Cr). Pre-issue shareholding stands at 4,87,87,456, which will increase to 6,32,01,870 post-issue.
Indogulf Cropsciences IPO carries a ₹18 (16.22%) GMP, reflecting investor sentiment.
Indogulf Cropsciences IPO Lot Size : Retail Minimum is 1 lot (135 shares) amounting to ₹14,985. Retail Maximum is 13 lots (1,755 shares) amounting to ₹194,805. SHNI Minimum is 14 lots (1,890 shares) amounting to ₹209,790. SHNI Maximum is 66 lots (8,910 shares) amounting to ₹989,010. BHNI Minimum is 67 lots (9,045 shares) amounting to ₹1,003,995.
The Lead Managers for Indogulf Cropsciences IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Systematix Corporate Services Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For detailed information, Refer to the Indogulf Cropsciences Limited RHP.
Indogulf Cropsciences IPO Details
Indogulf Cropsciences IPO Subscription
Indogulf Cropsciences IPO Application Wise Breakup (Approx)
Indogulf Cropsciences IPO Dates
- 26 Jun 2025Opening dateOpen
- 30 Jun 2025Closing dateClose
- 01 Jul 2025Allotment Date Allotment
- 02 Jul 2025Initiation of RefundsRefund
- 02 Jul 2025Credit of SharesCredit
- 03 Jul 2025Listing dateListing
Indogulf Cropsciences IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 135 | ₹14,985 |
| Retail Maximum | 13 | 1755 | ₹194,805 |
| SHNI Minimum | 14 | 1890 | ₹209,790 |
| SHNI Maximum | 66 | 8910 | ₹989,010 |
| BHNI Minimum | 67 | 9045 | ₹1,003,995 |
Indogulf Cropsciences IPO Reservation
Promoter Holding
Indogulf Cropsciences IPO Valuations
Indogulf Cropsciences Financial Information
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 597.81 | 542.25 | 517.51 | 413.59 |
| Revenue | 466.31 | 555.79 | 552.19 | 490.23 |
| Profit After Tax | 21.68 | 28.23 | 22.42 | 26.36 |
| EBITDA | 44.78 | 55.74 | 49.04 | 47.24 |
| Net Worth | 265.43 | 231.65 | 203.25 | 180.51 |
| Reserves and Surplus | 216.64 | 208.01 | 179.60 | 156.87 |
| Total Borrowing | 206.30 | 154.56 | 189.22 | 101.38 |
| Amount in ₹ Crore | ||||
About Indogulf Cropsciences IPO
Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.
The company manufactured Spiromesifen technical with 96.5% purity in 2019 and is one of the first indigenous manufacturers of Pyrazosulfuron Ethyl technical with 97% purity in India.
The company operates four manufacturing facilities in Samba (Jammu & Kashmir) and Nathupur (Haryana), covering approximately twenty acres, including two sites in Nathupur and one in Barwasni, Haryana.
The company has a sales network across 22 states and 3 Union Territories in India, with 169 business partners, 5,772 distributors, and 129 partners in 34 countries worldwide.
The company’s flexible, multi-purpose facilities allow diverse product manufacturing, adapting to customer needs. Its competitive advantage is strengthened by high regulatory barriers in the agrochemical industry, including costs and complex approvals.
Product Portfolio:
- Plant Nutrients: The company manufactures specialty fertilizers, bio-simulants, and performance products, including straight fertilizers and soil health products, to enhance soil fertility, stimulate root growth, and improve crop yields.
- Crop Protection Products: The company manufactures crop protection products, including insecticides, fungicides, herbicides, and bio-stimulants, designed to safeguard crops from pests, diseases, and weeds, ensuring healthy growth and productivity.
- Biologicals: The company offers biological products, including bio-stimulants and bio-fertilizers, to improve crop growth, nutrient uptake, stress tolerance, and overall sustainability, with products like Biogold, Indo Breeza, and Indo Mychoriza.
As of August 31, 2024, the company had 640 permanent employees.
Competitive Strengths:
- Diversified product portfolio and specialized products across all three verticals.
- Established distribution network in India and abroad.
- Backward integrated manufacturing infrastructure.
- Strong R&D and product development capabilities.
- Experienced Promoters and a strong management team.
Strength Of Indogulf Cropsciences IPO
1. Diversified product portfolio and specialized products across all three verticals.
2. Established distribution network in India and abroad.
3. Backward integrated manufacturing infrastructure.
4. Strong R&D and product development capabilities.
5. Experienced Promoters and a strong management team.
Risk Of Indogulf Cropsciences IPO
1. We are subject to regular inspections and audits, and the success and wide acceptability of our products is largely dependent upon our quality controls and standards. Any failure to comply with quality standards may adversely affect our business prospects and financial performance, including cancellation of existing and future orders which may expose us to warranty claims.
2. The value of our brands may be diluted if there is a change in the brand name for a known product, quality concern, negative publicity which could adversely affect our business, financial condition and results of operations.
3. Our historical cumulative average growth rate ("CAGR") in Revenue from Operations, EBITDA and PAT, may not be indicative of our future performance.
4. Under-utilization of our manufacturing capacities and an inability to effectively utilize our expanded manufacturing capacities could have an adverse effect on our business, future prospects and future financial performance.
5. Our inability to collect receivables and default in payment from our customers could result in the reduction of our profits and affect our cash flows.
6. Any shortfall in the supply of our components and raw materials or an increase in our component or raw material costs, or other input costs, may adversely affect the pricing and supply of our products and have an adverse effect on our business, results of operations and financial condition.
7. We intend to deploy a substantial portion of the Net Proceeds aggregating to ? 650.00 million towards funding our working capital requirements, which is based on certain assumptions. Any change in working capital requirements on account of such assumptions may materially adversely affect our results of operations and profitability.
8. The agrochemicals industry is capital intensive, and we may need to seek additional financing in the future to support our growth strategies. Any failure to raise additional financing could have an adverse effect on our business, results of operations, financial condition and cash flows.
9. The Offer Price, price to earnings ratio and market capitalization to revenue multiple based on the Offer Price of our Company, may not be indicative of the market price of the Company on listing or thereafter.
10. The determination of the Price Band is based on various factors and assumptions, and the Offer Price of our Equity Shares may not be indicative of the market price of our Equity Shares after the Offer.
Objectives Indogulf Cropsciences IPO
1. Funding working capital requirements of our Company
2. Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by our Company
3. Capital expenditure of our Company for setting up an in-house dry flowable (DF) plant at Barwasni, District Sonipat, Haryana
4. General corporate purposes
Company Contact Details
Indogulf Cropsciences Limited
501, Gopal Heights
Plot No - D-9,
Netaji Subhash Place
Delhi, New Delhi, 110034
Phone: +91 11 4004 0417
Email: cs@groupindogulf.com
Website: http://www.groupindogulf.com/
Registrar Contact Details
Lead Mangers
Lead Manager Reports
Indogulf Cropsciences IPO - FAQs
The Indogulf Cropsciences IPO is a MAINBOARD public issue comprising 18018017 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹200.00 Cr. The issue price has been fixed at ₹111 per equity share, and the minimum application size is 135 shares.
The IPO opens for subscription on 26 Jun 2025, and closes on 30 Jun 2025.
Bigshare Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
As of now, the current GMP stands at ₹18 (16.22%).